Chitilian H V, Laufer T M, Stenger K, Shea S, Auchincloss H
Transplantation Unit, Harvard Medical School, Massachusetts General Hospital, Boston 02114, USA.
Xenotransplantation. 1998 Feb;5(1):93-8. doi: 10.1111/j.1399-3089.1998.tb00014.x.
Previous studies have shown that CD4+ T cells are responsible for the great strength of cell-mediated xenograft rejection in the mouse. In vitro studies have suggested that this CD4+ response is to xenogeneic antigens that are presented indirectly. The present studies were carried out in order to determine whether the strength of cell-mediated xenograft rejection in vivo is dependent on the CD4+ indirect response. We grafted pig skin onto mice that express class II MHC antigens only on their thymic epithelial cells (II-4+ mice). These mice have normal numbers of functional peripheral CD4+ T cells; however they lack class II MHC expression on their antigen presenting cells and are thus incapable of mounting a CD4+ T cell-mediated indirect response. Xenograft survival was prolonged on these mice. Furthermore, administration of cyclosporine and anti-CD8 monoclonal antibodies to II-4+ recipients prolonged xenograft survival to at least the same extent as allograft survival, demonstrating that the strength of cell-mediated xenograft rejection resides in the CD4+ indirect response. Despite the increased survival time, xenograft rejection still occurred in the absence of the indirect pathway. Depletion of the II-4+ recipients of their CD4+ T cell population prolonged xenograft survival even further, suggesting the presence of a weaker CD4+ direct mechanism which was virtually undetectable in vitro.
以往的研究表明,在小鼠中,CD4+ T细胞是细胞介导的异种移植排斥反应强大力量的原因。体外研究表明,这种CD4+反应针对的是间接呈递的异种抗原。进行本研究是为了确定体内细胞介导的异种移植排斥反应的强度是否依赖于CD4+间接反应。我们将猪皮移植到仅在胸腺上皮细胞上表达II类MHC抗原的小鼠(II-4+小鼠)身上。这些小鼠具有正常数量的功能性外周CD4+ T细胞;然而,它们的抗原呈递细胞上缺乏II类MHC表达,因此无法产生CD4+ T细胞介导的间接反应。这些小鼠的异种移植存活时间延长。此外,给II-4+受体施用环孢素和抗CD8单克隆抗体可使异种移植存活时间延长至至少与同种异体移植存活时间相同的程度,这表明细胞介导的异种移植排斥反应的强度在于CD4+间接反应。尽管存活时间增加,但在没有间接途径的情况下仍会发生异种移植排斥反应。耗尽II-4+受体的CD4+ T细胞群体可进一步延长异种移植存活时间,这表明存在一种较弱的CD4+直接机制,这种机制在体外几乎检测不到。